BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2457435)

  • 1. Transcriptional inhibition of Ha-ras in interferon-induced revertants of ras-transformed mouse cells.
    Rimoldi D; Samid D; Flessate DM; Friedman RM
    Cancer Res; 1988 Sep; 48(18):5157-62. PubMed ID: 2457435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis.
    Mello ML; Contente S; Vidal BC; Planding W; Schenck U
    Exp Cell Res; 1995 Oct; 220(2):374-82. PubMed ID: 7556446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-induced modulation of human ras oncogene expression.
    Samid D; Schaff Z; Chang EH; Friedman RM
    Prog Clin Biol Res; 1985; 192():265-8. PubMed ID: 2417251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and morphological characteristics of phenotypic revertants appearing in interferon-treated mouse cells transformed by a human oncogene.
    Samid D; Chang EH; Friedman RM; Schaff Z; Greene JJ
    J Exp Pathol; 1985; 2(3):211-22. PubMed ID: 2431116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and phenotypic alterations caused by an inducible transforming ras oncogene introduced into rat liver epithelial cells.
    Huber BE; Cordingley MG
    Oncogene; 1988 Sep; 3(3):245-56. PubMed ID: 3060790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha affects LTR-controlled oncogene expression in transformed mouse fibroblasts at the post-transcriptional level.
    Seliger B; Stark G; Pfizenmaier K
    J Immunol; 1988 Sep; 141(6):2138-44. PubMed ID: 2844896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H; Geng Y; Pramanik R; Choubey D
    J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on reversion of the human activated c-Ha-ras-transformed cells].
    Ogiso Y
    Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of a specific protein in flat revertant cell lines derived from ras oncogene-transformed cells].
    Fujita H
    Hokkaido Igaku Zasshi; 1990 Mar; 65(2):210-20. PubMed ID: 2194920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA; Lee J; Voskas D
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
    Kivinen L; Pitkänen K; Laiho M
    Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
    Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
    Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased retinoylation in NIH 3T3 cells transformed with activated Ha-ras.
    Takahashi N; De Luca LM; Breitman TR
    Biochem Biophys Res Commun; 1997 Oct; 239(1):80-4. PubMed ID: 9345273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines.
    Hurta RA; Wright JA
    J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo.
    Kröger A; Dallügge A; Kirchhoff S; Hauser H
    Oncogene; 2003 Feb; 22(7):1045-56. PubMed ID: 12592391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
    Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.